SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
 
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Walker Matthew Alan

(Last) (First) (Middle)
C/O GREENLIGHT BIOSCIENCES HOLDINGS, PBC
200 BOSTON AVENUE, SUITE 3100

(Street)
MEDFORD MA 02155

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
02/02/2022
3. Issuer Name and Ticker or Trading Symbol
GreenLight Biosciences Holdings, PBC [ GRNA ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
1. Name and Address of Reporting Person*
Walker Matthew Alan

(Last) (First) (Middle)
C/O GREENLIGHT BIOSCIENCES HOLDINGS, PBC
200 BOSTON AVENUE, SUITE 3100

(Street)
MEDFORD MA 02155

(City) (State) (Zip)
1. Name and Address of Reporting Person*
BUILDERS VISION LLC

(Last) (First) (Middle)
110 N.W. 2ND STREET
SUITE 300

(Street)
BENTONVILLE AR 72712

(City) (State) (Zip)
Explanation of Responses:
Remarks:
Exhibit 24 Power of Attorney filed herewith. S2G Advisors, LLC has changed its name to Builders Vision, LLC. Mr. Walker's middle name is spelled Allen, not Alan.
No securities are beneficially owned.
/s/ David Kennedy, Attorney-in-fact for Matthew Allen Walker 02/04/2022
/s/ Lisa J. Forbes, as authorized officer of Builders Vision, LLC 02/04/2022
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
POWER OF ATTORNEY

     KNOW ALL BY THESE PRESENTS, that the undersigned hereby authorizes David
Kennedy of GreenLight Biosciences Holdings, PBC (the "Company") and John D.
Hancock of Foley Hoag LLP, each acting singly, to execute and cause to be filed
with the United States Securities and Exchange Commission any and all
documents or filings, including any amendments thereto, required to be so
filed. The undersigned hereby grants to the attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might
or could do personally present, with full power of substitution, resubstitution
or revocation, hereby ratifying and confirming all that such attorney-in-fact,
or such attorney-in-fact's substitute or substitutes, shall lawfully do or
cause to be done by virtue of this power of attorney and the rights and powers
herein granted. The undersigned acknowledges that the foregoing attorney-in-
fact, or such attorney-in-fact's substitute, in serving in such capacity at the
request of the undersigned, is not assuming, nor is the Company assuming, any
liability from the undersigned's responsibilities to comply with all applicable
laws, including Sections 13 and 16 of the Securities Exchange Act of 1934 (the
"Exchange Act").

     This Power of Attorney shall remain in full force and effect until the
earliest to occur of (a) the undersigned is no longer required to file Forms 3,
4 and 5 in accordance with Section 16(a) of the Exchange Act with respect to
the undersigned's holdings of and transactions in securities issued by the
Company, (b) revocation by the undersigned in a signed writing delivered to the
Company and the foregoing attorney-in-fact and (c) as to any attorney-in-fact
individually, until such attorney-in-fact is no longer employed by the Company
or employed by or a partner at Foley Hoag LLP, or another law firm representing
the Company, as applicable.

     IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 25th day of January, 2022.

/s/ Matthew Walker
Name: Matthew Walker